ARHGEF6 and medulloblastoma: It was found that miR-135a can inhibit cancer stem cell-driven medulloblastoma development by directly repressing the expression of ARHGEF6 (Hemmesi et al., 2015) and ARHGEF6 might be a hub gene in colorectal cancer (Wang and Zheng, 2014).